RETRACTED: New insights into molecular signaling pathways and current advancements in prostate cancer diagnostics & therapeutics
A Retraction of the Review Article
New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeutics
by Thakur N, Quazi S, Naik B, Jha SK and Singh P (2023) Front. Oncol. 13:1193736. doi: 10.3389/fonc.2023.1193736
Following publication, concerns were raised regarding the contribution of the authors of this article. Our investigation, conducted in accordance with Frontiers policies, confirmed a serious breach of our authorship policies and of publication ethics; the article is therefore retracted.
The retraction was approved by the Chief Editors of Oncology and the Chief Executive Editor of Frontiers. The authors do not agree to this retraction.
Citation: Frontiers Editorial Office (2023) Retraction: New insights into molecular signalling pathways and current advancements in prostate cancer diagnostics and therapeutics. Front. Oncol. 13:1343833. doi: 10.3389/fonc.2023.1343833
Received: 24 November 2023; Accepted: 27 November 2023;
Published: 07 December 2023.
Approved by:
Luisa Lanfrancone, European Institute of Oncology (IEO), ItalyCopyright © 2023 Frontiers Editorial Office. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.
*Correspondence: Frontiers Editorial Office, cmVzZWFyY2guaW50ZWdyaXR5QGZyb250aWVyc2luLm9yZw==